Fundraising FoxLyric
2 known investors
Find your way into Lyric
Sign up to find every way you can get introduced to Lyric
- Your email: who you already know at Lyric, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lyric team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
Investors · 2
Draper Associateslisted by Draper AssociatesSan Mateo · $500K – $5M
How we know: Draper Associates's portfolio page · Not right? Tell us
The Venture Collectivelisted by The Venture CollectiveMiami Beach · $100K – $500K
How we know: The Venture Collective's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Lyric do?
- Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
- Who are Lyric's investors?
- Lyric's investors include Draper Associates, The Venture Collective.